 |
|
| CAT# | Structured | Product Name | Standard Value | CAS No. | Molecular Formula | Molecular Weight | Specification | Operation |
|---|---|---|---|---|---|---|---|---|
| XL-TNFW168 |  |
Tenofovir Impurity 91 | 14047-28-0 | C8H11N5O | 193.21 | Details | ||
| XL-TNFW167 |  |
Tenofovir Impurity H | NA | C11H17N5O2 | 251.28 | Details | ||
| XL-TNFW166 |  |
Tenofovir Alafenamide | 379270-37-8;379270-38-9(Fumarate salt) | C21H29N6O5P | 476.47 | Details | ||
| XL-TNFW165 |  |
Tenofovir Alafenamide Fumarate | 379270-38-9;379270-37-8(free base) | C21H29N6O5P C4H4O4 | 476.47 116.07 | Details | ||
| XL-TNFW164 |  |
Tenofovir Alafenamide Hemifumarate salt[USAN] | 1392275-56-7;379270-37-8(free base) | C46H62N12O14P2 | 1069 | Details | ||
| XL-TNFW163 |  |
Tenofovir Alafenamide Impurity 1 | NA | C27H33N6O6PS | 600.63 | Details | ||
| XL-TNFW162 |  |
Tenofovir Alafenamide Impurity 2 | NA | C42H56N12O10P2S | 982.98 | Details | ||
| XL-TNFW161 |  |
Tenofovir Alafenamide-d6 | 379270-37-8 (non-labelled) | C21H23D6N6O5P | 482.5 | Details | ||
| XL-TNFW160 |  |
Tenofovir Alafenamide-d7 | NA | C21H22D7N6O5P | 483.51 | Details | ||
| XL-TNFW159 |  |
Tenofovir Disoproxil Fumarate IP Impurity A；Mono-POC PMPA | 211364-69-1 | C14H22N5O7P | 403.33 | Details | ||
| XL-TNFW158 |  |
Tenofovir Disoproxil Fumarate IP Impurity B;Mono-POC Methyl Tenofovir | 1246812-16-7 | C15H24N5O7P | 417.35 | Details | ||
| XL-TNFW157 |  |
Tenofovir Disoproxil Fumarate IP Impurity C Fumarate；MOC-POC Tenofovir Fumarate Salt | 1246812-43-0(free base) | C21H30N5O14P | 607.47 | Details | ||
| XL-TNFW156 |  |
Tenofovir disoproxil fumarate IP Impurity D Fumarate；USP Tenofovir Disoproxil Related Compound G | 1422284-15-8;1246812-40-7(free base) | C21H32N5O11P | 561.48 | Details | ||
| XL-TNFW155 |  |
Tenofovir disoproxil fumarate IP Impurity D;Mono-POC Isopropyl Tenofovir | 1246812-40-7;1422284-15-8(fumaric acid) | C17H28N5O7P | 445.41 | Details | ||
| XL-TNFW154 |  |
Tenofovir Disoproxil Fumarate IP Impurity E；Mono-POC Tenofovir 6-Isopropyl Carbamate | 1244022-56-7 | C18H28N5O9P | 489.43 | Details | ||
| XL-TNFW153 |  |
Tenofovir Disoproxil Fumarate IP Impurity F；Tenofovir Mono POC Dimer | 1962114-92-6 | C29H44N10O14P2 | 818.67 | Details | ||
| XL-TNFW152 |  |
Tenofovir Disoproxil Fumarate IP Impurity G Fumarate；USP Tenofovir Disoproxil Related Compound A | 1432630-26-6 | C23H34N5O14P | 635.51 | Details | ||
| XL-TNFW151 |  |
Tenofovir Disoproxil Fumarate IP Impurity H;USP Tenofovir Disoproxil Related Compound K | 1217542-13-6 | C19H30N5O10P | 519.44 | Details | ||
| XL-TNFW150 |  |
Tenofovir Disoproxil Fumarate IP Impurity I；Tri-POC Tenofovir Dimer | 1093279-77-6 | C34H52N10O17P2 | 934.78 | Details | ||
| XL-TNFW149 |  |
Tenofovir Disoproxil Fumarate IP Impurity J；Tenofovir Disoproxil Dimer | 1093279-76-5 | C39H60N10O20P2 | 1050.9 | Details |
Please feel free to contact us for more information.
Building 2, No. 3 Hanshan Road, Xuejia Town, New North District, Changzhou, Jiangsu Province, China
http://www.xianglongpharm.com
Tel: +86-519-88910898
Mobile: +86-18915873328
market@xianglongpharm.com
Xianglong Pharmaceutical
Wechat [scan]
WeChat official account
Please leave us a message and we will contact you as soon as possible.